Condition
Sevoflurane Anesthesia
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 4 (2)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07313969Not ApplicableCompleted
Ultra-Low-Flow Anesthesia and Carbon Footprint
NCT07046364Phase 4Recruiting
Remimazolam and Emergence Delirium in Pediatrics
NCT02054143Phase 4CompletedPrimary
The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries
NCT01571804Phase 2Completed
Pregabalin Reduce the Sevoflurane Requirement
Showing all 4 trials